Meloxicam Niche Generics (Meloxicam)

Meloxicam is an NSAID that reduces inflammation and pain by targeting the cyclooxygenase‑2 pathway, and it is indicated for the following conditions:

• Osteoarthritis: reduces joint pain and improves mobility.
• Rheumatoid arthritis: alleviates inflammatory joint symptoms and slows functional decline.
• Ankylosing spondylitis: diminishes spinal inflammation and associated pain.
• Acute pain: provides short‑term relief of moderate to severe pain.

• Meloxicam selectively inhibits the cyclooxygenase‑2 (COX‑2) enzyme, which converts arachidonic acid into prostaglandins that mediate inflammation, pain, and fever. By blocking COX‑2 while sparing COX‑1, meloxicam lowers prostaglandin synthesis at sites of inflammation, producing anti‑inflammatory, analgesic, and antipyretic effects with a comparatively lower risk of gastrointestinal mucosal injury than non‑selective NSAIDs.

Like all NSAIDs, meloxicam may cause adverse reactions that vary in frequency and severity.

Common Side Effects

• Gastrointestinal discomfort: nausea, dyspepsia, abdominal pain.
• Headache: mild to moderate headache.
• Dizziness: transient dizziness or vertigo.
• Edema: peripheral swelling.
• Elevated liver enzymes: mild transaminase increase.
• Skin rash: mild rash or pruritus.

Serious or Rare Side Effects

• Gastrointestinal ulceration or bleeding: serious ulcer or hemorrhage.
• Cardiovascular events: increased risk of myocardial infarction or stroke.
• Severe hepatic injury: hepatitis or liver failure.
• Renal impairment: acute kidney injury or worsening chronic kidney disease.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Anaphylaxis: life‑threatening allergic reaction.

When prescribing meloxicam, clinicians should consider several precautionary measures to minimize risks.

• Renal function: assess baseline renal function and monitor during therapy.
• Cardiovascular risk: avoid in patients with uncontrolled hypertension or recent cardiovascular events.
• Gastrointestinal history: use with caution in individuals with prior ulcer disease or bleeding.
• Pregnancy and lactation: avoid use unless benefits outweigh risks, as safety data are limited.
• Drug interactions: review concomitant medications that affect bleeding or renal function.
• Store at ambient temperature: keep below 25 °C in the original container, protected from moisture and light.

Meloxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Anticoagulants (warfarin, DOACs): increased bleeding risk.
• Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.
• Lithium: elevated serum lithium levels.

Moderate Interactions (Monitor Closely)

• SSRIs or SNRIs: modestly increased bleeding risk.
• Methotrexate: reduced clearance, monitor levels.
• ACE inhibitors/ARBs with diuretics: potential renal impairment.